GWave
Developing a non-invasive technology that continuously measures blood glucose levels using RF waves.
Developing a non-invasive technology that continuously measures blood glucose levels using RF waves.
GWave is a startup that is focused on developing a non-invasive technology for continuously measuring blood glucose levels using RF waves. The company, founded in 2017, operates within the Health Care and Medical Devices industries. Their flagship product, GWave, aims to revolutionize glucose monitoring by providing a non-invasive continuous glucose monitoring solution. The latest milestone for GWave was a $5.00M Series C investment on 10 August 2023. This funding round marks a significant step forward for the company as they continue to enhance their innovative approach to glucose monitoring. The investors involved in this latest round are not disclosed at this time. GWave's dedication to advancing glucose monitoring technology positions them as a key player in the medical device industry, with potential for substantial impact in the field of healthcare.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $5.00M | - | 10 Aug 2023 | |
| Series B | $11.70M | 1 |
|
12 Aug 2021 |
| Series A | $4.40M | 1 |
|
07 Jul 2021 |
No recent news or press coverage available for GWave.
We care about your data, and we'd love to use cookies make your experience better.
